Indeed, the p53 tumor suppressor gene has been proposed as a key determinant in metabolic stress resistance in pancreatic cancer cells [22-24] However, the identification of novel targets of metabolic stress resistance is urgently needed[10]. This evidence concerns the gene TP53 and familial pancreatic carcinoma.